Global Finance News
25 Sep 2026, 18:29
Humana Jumps 6.3% as Barclays Upgrades Stock to Overweight
Humana (NYSE: HUM) shares rose about 6.3% after Barclays upgraded the health insurer to Overweight from Equal Weight and raised its price target to $515 from $407.
Analyst Andrew Mok’s upgrade likely reflects a more constructive view on Humana’s earnings recovery and Medicare Advantage outlook, with expectations that improving pricing, benefit design and cost trends could support stronger margins over time. The higher target also suggests increased confidence in the company’s ability to recover profitability after recent pressure from elevated medical utilization.
Humana shares were trading around $404.23. Barclays’ new $515 target represents a meaningful increase from its prior $407 objective.
Humana (NYSE: HUM) shares rose about 6.3% after Barclays upgraded the health insurer to Overweight from Equal Weight and raised its price target to $515 from $407.
Analyst Andrew Mok’s upgrade likely reflects a more constructive view on Humana’s earnings recovery and Medicare Advantage outlook, with expectations that improving pricing, benefit design and cost trends could support stronger margins over time. The higher target also suggests increased confidence in the company’s ability to recover profitability after recent pressure from elevated medical utilization.
Humana shares were trading around $404.23. Barclays’ new $515 target represents a meaningful increase from its prior $407 objective.
